Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Francesc Cobo Valien
27 years of experience
Clinic is certified :
Follicular lymphoma treatment cost in Spain typically involves a comprehensive diagnosis of lymphomas ranging from $1,900 to $4,000 and primary interventions like autologous bone marrow transplantation, which runs from $40,000 to $70,000. Total expenses depend on the disease stage, specific immunotherapy protocols, and the hospital tier. Patients generally save 30–80% compared to the United States. Major treatment hubs include Barcelona, Madrid, and Pamplona.
Typical Follicular Lymphoma Treatment Costs in Spain
Bookimed Expert Insight: High-risk or relapsed cases benefit most from JCI-accredited centers like Clinica Universidad de Navarra. They offer advanced onco-hematology with a 5.0-star rating. For complex pediatric cases, SJD Barcelona Children’s Hospital provides specialized molecular medicine. This center is ranked among Europe's top three pediatric institutions. Patients seeking high-volume expertise should consider Centro Médico Teknon. It performs over 23,500 operations annually and is preferred by international celebrities.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Bone marrow transplantation | from $36,000 | from $140,000 | from $71,782 |
| Autologous bone marrow transplantation | from $31,500 | from $50,000 | from $40,000 |
| Allogenic bone marrow transplantation from an unrelated donor | from $80,000 | from $180,000 | from $150,000 |
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
Children's Hematologist specializing in bone marrow transplantation – Dr. Rives Sola provides focused care for pediatric cases at SJD Barcelona Children’s Hospital.
Dr. Francesc Cobo Valien specializes in lymphoma treatment with over 27 years of experience of experience. He combines clinical practice with cutting-edge research.
Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL) and lymphoproliferative disorders, with innovations in hematological disease analysis and treatments.